Trial intelligence / Profile preview

Omega-3 polyunsaturated fatty acids in severe chronic heart failure

2005-000778-31Phase 4Completed

Sponsor
Medical University of Vienna
Start
Apr 2005
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 4 trial of omega-3-acid triglycerides in chronic heart failure (CHF), sponsored by Medical University of Vienna. Primary endpoint: Flow-mediated vasodilation improvement. Started Apr 2005; status: completed.

02

Drugs

omega-3-acid triglycerides
03

Conditions

chronic heart failure (CHF)

Beyond the preview

Go deeper on 2005-000778-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-000778-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call